NCTR COVID-19/SARS-CoV-2 Publications
*As of 12/1/2022
Published in FY2023 |
---|
“Enhanced Virulence and Waning Vaccine-Elicited Antibodies Account for SARS-CoV-2 Delta and Kappa Breakthrough Infections in K18-hACE2 Passive Transfer Model.” iScience (December 2022). |
"Temporal Dynamics of SARS-CoV-2 Genome and Detection of Variants of Concern in Wastewater Influent from Two Metropolitan Areas in Arkansas.” Science of the Total Environment (November 2022). |
“Applying Imaging Mass Spectrometry to Define the N-glycan Profiles of Co-localized Virus and Immune Cell Infiltrates in Post-COVID-19 Infected Lung Autopsy Tissues.” Frontiers in Analytical Science (October 2022). |
Published in FY2022 |
---|
“Evaluation of the Mutagenic Effects of Molnupiravir and N4-hydroxycytidine in Bacterial and Mammalian Cell by HiFi Sequencing.” Environmental and Molecular Mutagenesis (August 2022). |
"NeuroCORD: A Language Model to Facilitate COVID-19-Associated Neurological Disorder Studies." International Journal of Environmental Research and Public Health (August 2022). |
“AI-Powered Drug Repurposing for Developing COVID-19 Treatments.” Reference Module in Biomedical Sciences (January 2022). |
“AI-Based Language Models Powering Drug Discovery and Development.” Drug Discovery Today (November 2021). |